Blis Technologies Limited has been the scientific leader in oral probiotics since 2002 and we continue to lead the way in oral probiotic supplements to support the health of the mouth and throat.
The probiotic strain BLIS K12™ (Streptococcus salivarius K12) is an advanced oral probiotic that supports ear, nose, and throat health and assists with fresh breath.
Professor Emeritus John Tagg first discovered the BLIS K12™ strain during his time in the microbiology department at University of Otago. He suffered from rheumatic fever as a teenager which was caused by Group A strep. His life has been dedicated to finding a probiotic approach to address Group A strep.
BLIS M18™ (Streptococcus salivarius M18) was discovered some years later. This strain focuses on supporting dental health and specifically in balancing the oral microbiome to help support the health of teeth and gums.
To this day, Professor Tagg continues to lead strain discovery in the BLIS Laboratory in Dunedin, New Zealand.